Journal:
:hepatitis monthly
0
ligita jancoriene department of infectious, chest diseases, dermatovenerology and alergology, faculty of medicine, vilnius university, vilnius, lithuania; department of infectious, chest diseases, dermatovenerology and alergology, faculty of medicine, vilnius university, vilnius, lithuania. tel: +37-68785870, fax: +37-52752790
dovile norvydaite department of otolaryngology and eye diseases, faculty of medicine, vilnius university, vilnius, lithuania
saulius galgauskas department of otolaryngology and eye diseases, faculty of medicine, vilnius university, vilnius, lithuania
evelina balciunaite department of xx, faculty of medicine, vilnius university, vilnius, lithuania
introduction patients with hepatitis c are commonly treated with combination of pegylated interferon alfa-2a and ribavirin. less than 1% of patients receiving this treatment experience very uncommon ophthalmological side effects such as optic neuropathy and vision disorder, which are usually subclinical, mild and reversible, not requiring the withdrawal of the treatment. retinopathy is the most...
